Taika Waititi promises a “fun” and “high stakes” Star Wars movie, aiming to recapture the original trilogy’s spirit. Meanwhile, Chris Pratt reveals he has a “strong vision” for Star-Lord’s future in the MCU, and Martin Scorsese is assembling a star-studded cast for a new horror film.
A new Dynatrace report reveals a major roadblock in enterprise AI. About half of all agentic AI initiatives are stuck in proof-of-concept or pilot stages, preventing companies from realizing their expected return on investment. The barriers aren’t technical, but revolve around governance, safety, an
The coworking market is surging back to life, but it looks completely different. Forget WeWork’s startup chaos—today’s growth is fueled by giants like Amazon and Pfizer taking flexible space for hybrid work teams.
Apple has topped Fortune’s World’s Most Admired Companies list for an incredible 19th straight year. The 2024 ranking highlights the growing influence of AI, with Nvidia landing at #4 and newcomers AMD and Workday cracking the top 50.
A veteran asset manager is sounding the alarm on OpenAI’s finances, comparing CEO Sam Altman to Enron’s Jeffrey Skilling. The warning comes as experts predict the company could run out of cash in the next 18 months.
Nearly a year after a famous memo pushed for AI over hiring, Shopify has an unexpected update. They’re hiring more entry-level workers than before. The reason is a crucial lesson for any leader.
A Chinese AI startup called MiniMax saw its stock price more than double on its first day of trading. The frenzy highlights a huge appetite for AI plays among retail investors, but it also raises big questions about sustainability and the unique dynamics of China’s tech scene.
A new report finds high consumer interest in letting AI assistants handle shopping and bills. But when it comes to checkout, trust quickly shifts from the AI to familiar financial institutions like banks and credit card networks.
Wabash National Corporation is permanently closing plants in Minnesota and Indiana, eliminating 270 positions. The move follows a 17.8% year-over-year drop in quarterly sales. Costs for the shutdown are estimated between $15 and $20 million.
A new review of studies finds that people who stop taking GLP-1 obesity medications like semaglutide regain weight quickly, about 1.8 pounds per month. This suggests many may need to stay on the drugs long-term to maintain results.
